As of 2025-07-09, the EV/EBITDA ratio of TRACON Pharmaceuticals Inc (TCON) is
-0.76.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TCON's latest enterprise value
is -7.78 mil USD. TCON's TTM EBITDA according to its financial statements is
10.20 mil USD. Dividing these 2
quantities gives us the above TCON EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
8.2x - 12.8x |
10.5x |
| Forward P/E multiples |
11.9x - 20.6x |
16.2x |
| Fair Price |
738.12 - 1,799.86 |
1,232.66 |
| Upside |
51517.0% - 125764.5% |
86100.2% |